Fig. 1
From: Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004–2018
Trends for the quantity and proportions of different subgroups among total primary DR-TB cases, Shandong, China, 2004–2018*. a Trends for MR-TB, MDR-TB, PDR-TB among total primary cases of TB; b Trends for primary DR-TB cases of different age (0–14, 15–44, 45–64, 65+); c Trends for primary DR-TB cases of different sex(male or female); d Trends for primary DR-TB cases with or without cavity; e Trends for primary DR-TB cases with or without smoking history; f Trends for primary DR-TB cases with or without drinking history; The proportions of each subgroups were calculated as follows: (the quantity of each subgroups/ the quantity of total primary DR-TB subgroups in the same year)*100%. The χ2 and linear regression results are shown in Table 5 in Appendix. TB, tuberculosis; DR-TB, drug-resistant tuberculosis; MR-TB, mono-resistant tuberculosis; MDR-TB, multi-resistant tuberculosis; PDR-TB, polydrug resistant tuberculosis. EMB, ethambutol; INH, isoniazid; RFP, rifampin; SM, streptomycin